Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 05, 2021 at 05:47 pm EDT
Share
Li Kang Biomedical Co., Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was TWD 98.222 million compared to TWD 65.605 million a year ago. Operating income was TWD 14.312 million compared to TWD 4.270 million a year ago. Net income was TWD 12.408 million compared to TWD 8.146 million a year ago. Basic earnings per share was TWD 0.56 compared to TWD 0.37 a year ago. For the half year, total revenue was TWD 191.837 million compared to TWD 134.221 million a year ago. Operating income was TWD 28.646 million compared to TWD 9.046 million a year ago. Net income was TWD 22.437 million compared to TWD 12.486 million a year ago. Basic earnings per share was TWD 1.01 compared to TWD 0.56 a year ago.
Li Kang Biomedical Co., Ltd. formerly BAFO TECHNOLOGIES CORP., is engaged in the manufacture and sale of computer, communication and consumer (3C) product cables and circumscribed computer peripheral products, as well as communication products. The Company offers unshielded twisted pair (UTP) cables, monitor cables, small computer system interface (SCSI) cables, universal serial bus (USB) cables, wireless hopping/mesh access points, wireless modules, and wireless vehicle communication systems, among others. The Company distributes its products within the domestic market and to overseas markets, including Europe, the Americas and the rest of Asia.
LI KANG BIOMEDICAL CO., LTD. 
